Triglimilife 2mg/500mg/0.2mg Tablet SR
Marketer
Lakshya Life Sciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Triglimilife 2mg/500mg/0.2mg Tablet SR
Diabex Trio 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, helping regulate blood glucose. Diabex Trio 2mg/500mg/0.2mg ER Tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue this medication as prescribed, even if feeling well or achieving target glucose levels. Discontinuing without medical supervision risks elevated blood sugar, increasing the likelihood of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this is one component of a comprehensive treatment plan, which must include a doctor-approved diet, regular physical activity, and weight management; lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect of Diabex Trio 2mg/500mg/0.2mg ER Tablets. Learn to recognize its symptoms—sweating, dizziness, headache, trembling—and how to address them promptly. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are crucial. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is also possible. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver impairment. Inform your doctor of any prior heart conditions before commencing treatment; it may be contraindicated. Consult your physician before use during pregnancy or breastfeeding. Routine blood glucose monitoring is necessary, and your doctor might recommend blood tests to assess blood cell counts and liver function.
Uses of Triglimilife 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Triglimilife 2mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Triglimilife 2mg/500mg/0.2mg Extended-Release Tablets on an empty stomach.
Common Side effects of Triglimilife 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Triglimilife 2mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Triglimilife 2mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Take it on an empty stomach.
How Triglimilife 2mg/500mg/0.2mg Tablet SR works:
Extended-release Triglimilife tablets (2mg/500mg/0.2mg) contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Triglimilife 2mg/500mg/0.2mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Triglimilife 2mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Triglimilife tablets (2mg/500mg/0.2mg) are likely unsuitable for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is a possibility if your blood glucose level is abnormally low or elevated. Refrain from driving should these conditions arise.
KidneyUNSAFE
The use of Triglimilife 2mg/500mg/0.2mg SR tablets is inadvisable for individuals with kidney impairment and should be avoided. Patients with severe kidney disease should not take this medication. A physician's consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Triglimilife 2mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, Triglimilife 2mg/500mg/0.2mg SR tablets are unsuitable for patients with severe liver dysfunction.
What if you forget to take Triglimilife 2mg/500mg/0.2mg Tablet SR :
Should you forget to take a Triglimilife 2mg/500mg/0.2mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triglimilife 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Medication |
3,018 People bought this recently